Abstract
Gene expression profiling (GEP, AlloMap) has become the standard of care in heart transplant patient management with over 100,000 performed. OAR is a prospective observational heart transplant registry study with integrated GEP testing to elucidate factors that contribute to favorable long term outcomes. Gene subsets were examined for correlation with clinical factors with the goal of identifying those associated with expression patterns that shed light on the underlying mechanisms of acute cellular rejection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
